so there are a handful of cancers that are uh derived from inherited mutations so Lynch syndrome is an example of that uh hereditary polyposis is an example of that where you have a gene that gets passed through the germ line
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
so there are a handful of cancers that are uh derived from inherited mutations so Lynch syndrome is an example of that uh hereditary polyposis is an example of that where you have a gene that gets passed through the germ line
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so there are a handful of cancers that are uh derived from inherited mutations so Lynch syndrome is an example of that hereditary polyposis is an example of that where you have a gene that gets passed through the germ line and that Gene codes for a protein like all genes do and it's either you have too much of a gene or too little of a gene so it's either a gene that promotes cancer or and you have too much of that or it's a gene that prevents cancer and you have too little of it or a dysfunctional version of it right so braa is an example of that braa is hereditary braa codes for a protein and the the women and men but mostly the women that we think about who have a braa mutation that all in some cases almost guarantees breast cancer it's because of a defective copy so it's like they don't get the protein that they need to protect them from breast cancer
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.